Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia
Acute Myeloid Leukaemia (AML) is a rare but serious group of diseases that require critical decision-making for curative treatment. Over the past decade, scientific discovery has revealed dozens of prognostic gene mutations for AML while sequencing costs have plummeted. In this study, we compared th...
Asıl Yazarlar: | Cressman, S, Karsan, A, Hogge, DE, McPherson, E, Bolbocean, C, Regier, DA, Peacock, SJ |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Wiley
2016
|
Benzer Materyaller
-
Quality of life and socioeconomic indicators associated with survival of myeloid leukemias in Canada
Yazar:: Sonya Cressman, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01) -
Hypocellular Acute Myeloid Leukaemia-A Diagnostic Conundrum
Yazar:: Sindhura Lakshmi Koulmane Laxminarayana, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01) -
Acute Myeloid Leukaemia with Plasmacytosis
Yazar:: Yasmin Akhtar, Saqib Qayyum Ahmad, Shahid Jamal
Baskı/Yayın Bilgisi: (2016-12-01) -
Exploring the acute myeloid leukaemias
Yazar:: TB Thapa
Baskı/Yayın Bilgisi: (2013-10-01) -
Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
Yazar:: Eden, O, ve diğerleri
Baskı/Yayın Bilgisi: (1998)